GE HealthCare: quarterly revenue hits $5.51B as profit climbs 38%

what happened

According to a TradingView summary of the company's 10-Q filing, GE HealthCare booked $5.51 billion in revenue for the third quarter of 2026, compared with $5.14 billion a year earlier. Profit attributable to shareholders rose to $615 million from $446 million, and diluted earnings per share climbed to $1.36 from $0.98.

On an organic basis, sales grew 6.2%. Pharmaceutical Diagnostics (PDx) was the strongest unit, expanding 13.8% on volume and pricing, while Advanced Imaging Solutions (AIS) added 4.5%. Patient Care Solutions revenue jumped 8.5% in the quarter, although its nine-month total fell 4%. U.S. and Canadian sales were up 13.3%, EMEA was roughly flat, and China and the rest of the world grew modestly.

The company flagged tariffs, geopolitical disruption and competition in China as ongoing pressures, and said its mitigation steps may not fully offset tariff costs.

why it matters

For markets, the report pairs solid top-line and profit growth with a clear warning about tariff costs. Traders will likely weigh whether demand and pricing in North America can offset weaker results elsewhere in the coming quarters.

market impact

GE HealthCare shares: profit growth supports the stock, tariff costs limit the upside

• ↔GE HealthCare shares mixed — strong profit growth supports the stock, while tariffs and China competition weigh on it

tags

instruments